Results 71 to 80 of about 750,934 (136)

PD-1 inhibitor improves radiosensitivity by tumor vessel normalization. [PDF]

Br J Cancer
Hao S, Ai D, Wang Q, Zhang X, Ma X, Tseng I, Shen J, Chen Y, Liu Q, Deng J, Zhu H, Kong Z, Zhao K.   +12 more
europepmc   +1 more source

Discovery of d‑Miniprotein Inhibitors of PD-1/PD-L1 Interaction via Mirror-Image Phage Display against Synthetic d‑PD‑1. [PDF]

JACS Au
Zhou H, Wu H, Zhong Z, Blasco P, Zeng J, Wang J, Liu H, Li X.   +7 more
europepmc   +1 more source

Teriflunomide modulates the PD-1/PD-L1 axis and enhances antitumor immunity in colorectal cancer. [PDF]

Oncogenesis
Han JH, Lee EJ, Park YH, Ha JH, Ahmed KR, Choi JG, Chung HS.   +6 more
europepmc   +1 more source

Postoperative Adjuvant Chemoradiotherapy ± PD-1 Inhibitor for Locally Advanced Head and Neck Squamous Cell Carcinoma. [PDF]

Cancer Rep (Hoboken)
Wang Z, He Q, Jiang D, Cheng S, Gao J, Wang Y, Fu S, Cui QY, Yang Y, Lv L, Xu Y, Li Y, Tian R, Ge C, Li R.   +14 more
europepmc   +1 more source

Phase 2 Trial of PD-1 Inhibitor Sintilimab in Recurrent/Progressive Meningioma. [PDF]

CNS Neurosci Ther
Wang Y, Wang C, Yin S, Yu C, Li X, Kang X, Yang S, Xie W, Lin Y, Wu Z, Li W, Chen F.   +11 more
europepmc   +1 more source

Correction: Endocrine advantages of PD-1/PD-L1 therapy: Comparative analysis of FAERS-JADER. [PDF]

PLoS One
Gao Y, Jiang S, Cui Y, Wang Y, Yu L.
europepmc   +1 more source

Molecular remodeling of cancer-associated fibroblasts in breast cancer patients receiving anti-PD-1 immunotherapy. [PDF]

Front Oncol
Do KV, Tran AV, Pham AD, Mac TT, Pham TL, Do HN.   +5 more
europepmc   +1 more source

Immunotherapy for Glioblastoma: A Focus on PD-1/PD-L1 Inhibitors. [PDF]

Cancers (Basel)
Zoi V, Galani V, Sioka C, Alexiou GA, Kyritsis AP.   +4 more
europepmc   +1 more source

PD-1 Ligand Inhibitor [PDF]

, 2020
openaire   +1 more source

Prolonged TNF-α stimulation induces a PD-1-associated exhaustion-like phenotype in mesenchymal stromal cells. [PDF]

Front Cell Dev Biol
Matsunaga N, Akiyama K, Mun AY, Zou T, Ito K, Tagashira R, Kuboki T.   +6 more
europepmc   +1 more source